// App-Quantinova.ai

BSH19‐EP‐040 : A Quality Improvement Project Assessing Concordance with British Society for Haematology (BSH) Guidelines Regarding Management of Diffuse Large B‐Cell Lymphoma

Researchers

Presenter

  • P. Mahapatra

Principal Investigators

  • J. Arnold

Medical Centers

  • Gastroenterology, Royal Hampshire County Hospital, Winchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Chronic kidney disease

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • Renal disease

  • Neutropenia

  • Lymphomas

  • Acquired immunodeficiency syndrome

Biomarkers

  • DNA Damage Inducible Transcript 3

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisolone

  • Vincristine

  • Doxorubicin

  • Sitavig

  • Rituximab

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved